TNBC is characterized by an aggressive clinical course with a poor prognosis (Gluz et al., 2009). Due to the absence of all three hormonal receptors, TNBC do not respond well to targeted receptor treatment’s, which are commonly used in case of other types of breast cancer (De Laurentiis et al., 2016). The current choices for treatment for triple negative breast cancer include chemotherapy, radiation, and combination therapies (Hurvitz & Mead, 2015). These treatments pose several side-effects such as loss of hair follicles, toxicity, damage to healthy cells, and their high costs (Botchkarev, 2003; Du, Osborne, & Goodwin, 2002; Early Breast Cancer Trialists’ Collaborative Group, 2005). Due to the difficulty in treating TNBC and the harsh side effects of treatment, there is a need to find naturally available anti-cancer agents with the ability to treat
TNBC is characterized by an aggressive clinical course with a poor prognosis (Gluz et al., 2009). Due to the absence of all three hormonal receptors, TNBC do not respond well to targeted receptor treatment’s, which are commonly used in case of other types of breast cancer (De Laurentiis et al., 2016). The current choices for treatment for triple negative breast cancer include chemotherapy, radiation, and combination therapies (Hurvitz & Mead, 2015). These treatments pose several side-effects such as loss of hair follicles, toxicity, damage to healthy cells, and their high costs (Botchkarev, 2003; Du, Osborne, & Goodwin, 2002; Early Breast Cancer Trialists’ Collaborative Group, 2005). Due to the difficulty in treating TNBC and the harsh side effects of treatment, there is a need to find naturally available anti-cancer agents with the ability to treat